Component,Publication Grant Number,Publication Doi,Publication Journal,Pubmed Id,Pubmed Url,Publication Title,Publication Year,Publication Keywords,Publication Authors,Publication Abstract,Publication Assay,Publication Tumor Type,Publication Tissue,Publication Dataset Alias,Publication Accessibility,PublicationView_id,Id,entityId
PublicationView,CA280829,10.1158/0008-5472.can-23-0398,Cancer Res,37791818,https://pubmed.ncbi.nlm.nih.gov/37791818,Stroma-Mediated Breast Cancer Cell Proliferation Indirectly Drives Chemoresistance by Accelerating Tumor Recovery between Chemotherapy Cycles,2023,,"Daria Miroshnychenko, Tatiana Miti, Pragya Kumar, Anna Miller, Mark Laurie, Nathalia Giraldo, Marilyn M Bui, Philipp M Altrock, David Basanta, Andriy Marusyk","The ability of tumors to survive therapy reflects both cell-intrinsic and microenvironmental mechanisms. Across many cancers, including triple-negative breast cancer (TNBC), a high stroma/tumor ratio correlates with poor survival. In many contexts, this correlation can be explained by the direct reduction of therapy sensitivity induced by stroma-produced paracrine factors. We sought to explore whe(Read more on Pubmed)",Mathematical Modeling,Triple-Negative Breast Carcinoma       ,Breast,Not Applicable,Open Access,37791818,b0505d5d-9614-4476-96ca-de179a512666,syn53693591
